









Markets
/
Stocks
/
nasdaq-ifrx
/

InflaRx NV

IFRX

View Detailed Chart

0.802USD

-0.047-5.60%

Close 05/30, 16:00（ET）Quotes delayed by 15 min

50.81MMarket Cap

LossP/E TTM



InflaRx NV

0.802

-0.047-5.60%

Company

Intraday

30m

Today

-5.60%

5 Days

-56.62%

1 Month

-52.79%

6 Months

-67.38%

Year to Date

-67.51%

1 Year

-43.88%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts

BUY

Current Rating

5.286

Target Price

521.78%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

557

Total

Median

Average

Company name

Ratings

Analysts

InflaRx NV

IFRX

Exact Sciences Corp

EXAS

CRISPR Therapeutics AG

CRSP

Regeneron Pharmaceuticals Inc

REGN

Intellia Therapeutics Inc

NTLA

IQVIA Holdings Inc

IQV

...

112

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(9)

Neutral(2)

Buy(0)

Indicators

Sell(3)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.212

Neutral

RSI(14)

33.015

Neutral

STOCH(KDJ)(9,3,3)

23.802

Sell

ATR(14)

0.224

High Vlolatility

CCI(14)

-222.212

Oversold

Williams %R

88.517

Oversold

TRIX(12,20)

0.731

Sell

StochRSI(14)

12.350

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.414

Sell

MA10

1.574

Sell

MA20

1.628

Sell

MA50

1.348

Sell

MA100

1.668

Sell

MA200

1.724

Sell

News

More news coming soon, stay tuned...

Company

Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.

Company codeIFRX

CompanyInflaRx NV

CEOProf. Niels C. Riedemann, M.D., Ph.D

Websitehttps://www.inflarx.de/